Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck
1 clinical trials · Condition
◉ Watch Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck
| Record | Firm | Date |
|---|---|---|
| Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck (NCT02319044) | AstraZeneca | 2015-04-15 |
Track Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck automatically
Every clearance here is in the API, with alerts when new ones post.